TOPICS

Tag: alopecia areata

Koilonychia in a Patient with Alopecia Areata

J Clin Aesthet Dermatol. 2021;14(2):42–43. by Noureddine Litaiem, MD; Olfa Charfi, MD; Takwa Bacha, MD; and Faten Zeglaoui, MD, PhD All authors are with the Department of Dermatology at Charles Nicolle Hospital in Tunis, Tunisia. FUNDING: No funding was provided for this article. DISCLOSURES: The authors report no conflicts of interest relevant to the content

CONTINUE READING »

Letters to the Editor: Long-term Treatment with Tofacitinib in Severe Alopecia Areata: An Update

Dear Editor: Tofacitinib is a Janus kinase (JAK) 1/3 inhibitor that has been approved by the United States Food and Drug Administration for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. An increasing number of studies have demonstrated the efficacy of tofacitinib in treatment of alopecia areata (AA).1–6 Treatment duration in these studies

CONTINUE READING »